HOME › DRUGS › TIGECYCLINE
ACTIVE SUBSTANCE / INN

TIGECYCLINE

Brand name(s): Tygacil, TIGECYCLINE, Tigecycline Accord, TYGACIL
FDA LISTED
EMA LISTED
PRESCRIPTION
APPLICATION WITHDRAWN
DISCONTINUED
Soft Tissue Infections
ANDA206335
ACTIVE SUBSTANCE
Tigecycline
REGULATORS
FDA · EMA
SPONSORS / MAH
EUGIA PHARMA, PF PRISM CV, Accord Healthcare Ltd
TOTAL APPLICATIONS
6
FDA APPLICATIONS (DRUGS@FDA)
BRAND NAMEAPPLICATIONSPONSORSTATUS
TIGECYCLINEANDA206335EUGIA PHARMAPrescription
TIGECYCLINENDA208744ACCORD HLTHCARE INCDiscontinued
TYGACILNDA021821PF PRISM CVPrescription
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
TygacilPfizer Europe MA EEIGAuthorised24/04/2006Bacterial Infections;Skin Diseases, Bacterial;Soft Tissue Infections
Tigecycline AccordAccord Healthcare S.L.U.Authorised17/04/2020Soft Tissue Infections;Intraabdominal Infections;Bacterial Infections;Skin Disea…
Tigecycline AccordAccord Healthcare LtdApplication withdrawnSoft Tissue Infections

FULL INTELLIGENCE ON TIGECYCLINE

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →